1536-4844/asset/IBD_left.gif?v=1&s=9aca2b5041534c51cac4bb66560294c77a457a07)
1536-4844/asset/IBD_right.gif?v=1&s=402e3e241083497ae622916e85e47f64138255a4)
Basic Science Review
You have full text access to this OnlineOpen article
Adherent-invasive Escherichia coli in inflammatory bowel disease
Article first published online: 2 MAY 2007
DOI: 10.1002/ibd.20176
Copyright © 2007 Crohn's & Colitis Foundation of America, Inc.
Additional Information
How to Cite
Rolhion, N. and Darfeuille-Michaud, A. (2007), Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis, 13: 1277–1283. doi: 10.1002/ibd.20176
Publication History
- Issue published online: 11 SEP 2007
- Article first published online: 2 MAY 2007
- Manuscript Accepted: 2 APR 2007
- Manuscript Received: 29 MAR 2007
Funded by
- Ministère de la Recherche et de la Technologie. Grant Number: EA3844
- INRA. Grant Number: USC 2018
- Association F. Aupetit
- Institut de Recherche des Maladies de l'Appareil Digestif (IRMAD laboratoire Astra France)
REFERENCES
- 1. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol. 1997; 92: 5S–11S.
- 2. Intestinal microflora in human and experimental inflammatory bowel disease. Curr Opin Gastroenterol. 2001; 17: 324–330.
- 3. Inflammatory bowel disease. N Engl J Med. 2002; 347: 417–429.
- 4, . Microbial factors in inflammatory bowel disease. Gastroenterol Clin North Am. 2002; 31: 41–62.
- 5. Host-flora interactions in inflammatory bowel disease. Inflamm Bowel Dis. 2004; 10(Suppl 1): S16–24.
- 6, , , et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun. 1998; 66: 5224–5231.
- 7, , , et al. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest. 1996; 98: 945–953.
- 8, , , et al. T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol. 1997; 150: 91–97.
- 9, , , et al. Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet. 1991; 338: 771–774.
- 10, , , et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002; 122: 44–54.
- 11, , , et al. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease. Am J Gastroenterol. 2002; 97: 939–946.Direct Link:
- 12, , , et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology. 1998; 115: 1405–1413.
- 13, , , et al. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther. 2006; 24(Suppl 3): 11–18.
- 14, , , et al. Dysbiosis in inflammatory bowel disease. Gut. 2004; 53: 1–4.
- 15, , . Pathogenic Escherichia coli. Nat Rev Microbiol. 2004; 2: 123–140.
- 16, , , et al. Implication of mitogen-activated protein kinases in T84 cell responses to enteropathogenic Escherichia coli infection. Infect Immun. 2001; 69: 1298–1305.
- 17, , . Enteropathogenic Escherichia coli: stimulating neutrophil migration across a cultured intestinal epithelium without altering transepithelial conductance. J Pediatr Gastroenterol Nutr. 2003; 36: 253–260.
- 18, , , et al. EPEC-activated ERK1/2 participate in inflammatory response but not tight junction barrier disruption. Am J Physiol Gastrointest Liver Physiol. 2001; 281: G890–898.
- 19, , . PKC zeta participates in activation of inflammatory response induced by enteropathogenic E. coli. Am J Physiol Cell Physiol. 2003; 285: C512–521.
- 20, , , et al. Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol. 2006; 290: G685–694.
- 21, , , et al. Flagellin of enteropathogenic Escherichia coli stimulates interleukin-8 production in T84 cells. Infect Immun. 2003; 71: 2120–2129.
- 22, , , et al. Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-kappaB and MAP kinase pathways and the upregulated expression of interleukin 8. Cell Microbiol. 2002; 4: 635–648.
- 23, , , et al. Enterohemorrhagic Escherichia coli infection induces interleukin-8 production via activation of mitogen-activated protein kinases and the transcription factors NF-kappaB and AP-1 in T84 cells. Infect Immun. 2002; 70: 2304–2310.
- 24, , . Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration. Infect Immun. 2001; 69: 6148–6155.
- 25, , , et al. Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells. Infect Immun. 1999; 67: 5985–5993.
- 26, , , et al. Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression. Infect Immun. 2001; 69: 6140–6147.
- 27, , , et al. The Afa/Dr adhesins of diffusely adhering Escherichia coli stimulate interleukin-8 secretion, activate mitogen-activated protein kinases, and promote polymorphonuclear transepithelial migration in T84 polarized epithelial cells. Infect Immun. 2003; 71: 1068–1074.
- 28, , , et al. Aggregative adherence fimbriae contribute to the inflammatory response of epithelial cells infected with enteroaggregative Escherichia coli. Cell Microbiol. 2005; 7: 1565–1578.
- 29, , , et al. Enteroaggregative Escherichia coli expresses a novel flagellin that causes IL-8 release from intestinal epithelial cells. J Clin Invest. 2000; 105: 1769–1777.
- 30. The bacterial weaponry: lessons from Shigella. Ann N Y Acad Sci. 2006; 1072: 307–312.
- 31, , , et al. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2001; 2: 736–742.
- 32, , , et al. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat Immunol. 2007; 8: 47–56.
- 33, , , et al. An immunocytochemical search for infectious agents in Crohn's disease. Mod Pathol. 1993; 6: 212–219.
- 34, , , et al. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology. 1995; 108: 1396–1404.
- 35, , , et al. [ Bacterial translocation in Crohn disease]. Gastroenterol Clin Biol. 1992; 16: 777–781.
- 36, , , et al. Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn's disease surgery. Br J Surg. 1984; 71: 623–625.
- 37, , , et al. Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. Gastroenterology. 2004; 127: 80–93.
- 38, , , et al. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease. Gut. 2006 (in press).
- 39, , et al. Bacterial overgrowth in the neoterminal ileum after ileocolonic resection for Crohn's disease. Gastroenterology. 1997; 112: A1023.
- 40, , , et al. Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut. 2006; 55: 1760–1767.
- 41, , , et al. Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. Inflamm Bowel Dis. 2005; 11: 481–487.
- 42, , . Escherichia coli antibodies in patients with inflammatory bowel disease. Gut. 1978; 19: 108–113.
- 43, . Radioimmunologic measurements of naturally occurring bacterial antibodies. I. Human serum antibodies reactive with Escherichia coli in gastrointestinal and immunologic disorders. J Lab Clin Med. 1973; 82: 125–136.
- 44, , , et al. Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease. Gastroenterology. 2006; 130: 1078–1085.
- 45, , , et al. Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens. Gastroenterology. 2002; 123: 689–699.
- 46, , , et al. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype. Am J Gastroenterol. 2004; 99: 2376–2384.Direct Link:
- 47, , , et al. High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot study. Dig Dis Sci. 2004; 49: 1280–1286.
- 48, , , et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology. 2004; 126: 414–424.
- 49, , . OmpC and the sigma(E) regulatory pathway are involved in adhesion and invasion of the Crohn's disease-associated Escherichia coli strain LF82. Mol Microbiol. 2007; 63: 1684–1700.
- 50, , . Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut. 1992; 33: 646–650.
- 51, . Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea. BMJ. 1988; 297: 102–104.
- 52, , , et al. Early mucosal changes in Crohn's disease. Gut. 1993; 34: 375–381.
- 53, , . Pathogenesis of aphthoid ulcers in Crohn's disease: correlative findings by magnifying colonoscopy, electron microscopy, and immunohistochemistry. Gut. 1996; 38: 724–732.
- 54, . The “early” ulcerative lesion of Crohn's disease: correlative light- and scanning electron-microscopic studies. J Clin Gastroenterol. 1980; 2: 11–19.
- 55, , , et al. Invasive E. coli strains are increased in Crohn's disease. Gastroenterology. 2006; 130: A–362.
- 56, , , et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004; 127: 412–421.
- 57, , , et al. Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease. Infect Immun. 1999; 67: 4499–4509.
- 58, . Entry of Shigella flexneri into HeLa cells: evidence for directed phagocytosis involving actin polymerization and myosin accumulation. Infect Immun. 1987; 55: 2681–2688.
- 59, . Comparison of the invasion strategies used by Salmonella cholerae-suis, Shigella flexneri and Yersinia enterocolitica to enter cultured animal cells: endosome acidification is not required for bacterial invasion or intracellular replication. Biochimie. 1988; 70: 1089–1099.
- 60, , . A comparison of HEp-2 cell invasion by enteropathogenic and enteroinvasive Escherichia coli. FEMS Microbiol Lett. 1990; 57: 83–86.
- 61, . Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes. J Cell Biol. 1989; 109: 1597–1608.
- 62, , . Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. Mol Microbiol. 2001; 39: 1272–1284.
- 63, , , et al. Regulatory and functional co-operation of flagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn's disease. Mol Microbiol. 2003; 48: 781–794.
- 64, , , et al. Involvement of lipoprotein NlpI in the virulence of adherent invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease. Infect Immun. 2004; 72: 2484–2493.
- 65, , , et al. Strong decrease in invasive ability and outer membrane vesicle release in Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 with the yfgL gene deleted. J Bacteriol. 2005; 187: 2286–2296.
- 66, , . Helicobacter pylori outer membrane vesicles modulate proliferation and interleukin-8 production by gastric epithelial cells. Infect Immun. 2003; 71: 5670–5675.
- 67, . Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response. Microbes Infect. 2006; 8: 2400–2408.
- 68, , , et al. Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death. Infect Immun. 2001; 69: 5529–5537.
- 69, . Pathogen-induced apoptosis of macrophages: a common end for different pathogenic strategies. Cell Microbiol. 2000; 2: 265–273.
- 70, , , et al. The Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 replicates in mature phagolysosomes within J774 macrophages. Cell Microbiol. 2006; 8: 471–484.
- 71, , , et al. HtrA stress protein is involved in intramacrophagic replication of adherent and invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease. Infect Immun. 2005; 73: 712–721.
- 72, . Granulomatous infections: etiology and classification. Clin Infect Dis. 1996; 23: 146–158.
- 73, , , et al. Bacterial DNA within granulomas of patients with Crohn's disease—detection by laser capture microdissection and PCR. Am J Gastroenterol. 2004; 99: 1539–1543.Direct Link:
- 74, . Undersokninger over en med specifika granulom forlopande honssjukdom orsakad av mukoida kolibacterier (koligranuloma). Skand Veterinartidskr. 1945; 35: 449–505.
- 75, , . The comparative importance of E. coli antigen in granulomatous colitis of Boxer dogs. Apmis. 2005; 113: 420–425.
- 76, . Pyogranulomatous typhlitis and hepatitis of market turkeys. Avian Dis. 1992; 36: 1070–1075.
- 77
- 78, , , et al. Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs. Infect Immun. 2006; 74: 4778–4792.
- 79, , , et al. An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells. Cell Microbiol. 2004; 6: 423–433.
- 80, , , et al. Adherent-invasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro. Cell Microbiol. 2007 9: 1252–1261.
- 81, , , et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411: 599–603.
- 82, , , et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001; 411: 603–606.
- 83, , , et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005; 307: 731–734.
- 84, , , et al. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology. 2003; 124: 993–1000.
- 85, , , et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology. 2000; 119: 305–309.
- 86, , , et al. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci. 2000; 45: 1462–1464.
- 87, , , et al. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet. 1999; 354: 635–639.
- 88, , , et al. Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther. 1999; 13: 1103–1108.
- 89, , , et al. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut. 2004; 53: 1617–1623.